GRS has been increasingly active in the MedTech space over the past few years with the number one driving factor being the new EU medical device and in-vitro diagnostic regulations which will come into full force as early as April or May this year. It's taken many years to reach this moment but it's here now, it's happening and it's very real!

The impact of these new regulations must not be underestimated and here at GRS we are working hard at delivering a full-service solution to medical device and IVD companies. Already we have gained considerable experience assessing European and global portfolios against the new EU regulations and devising strategies on how to achieve compliance during the 3 and 5-year transition periods (even though the text isn't completely set in stone yet).

Our fabulous team of MedTech subject matter experts are absolutely critical in ensuring the survival and success of our MedTech clients and this award is a reflection of the superb support and knowledge they provide.